non affective psychosis

Related by string. * nOn . nons . NON . - - Non : Non GAAP Financial . non farm payrolls . Non Aligned Movement NAM . Non GAAP net / Affective : affective psychosis . seasonal affective disorder . Seasonal Affective Disorder . Seasonal Affective Disorder SAD / Psycho Sid . Psychosis : Parkinson disease psychosis . severe postpartum psychosis . postpartum psychosis . Postpartum psychosis * *

Related by context. All words. (Click for frequent words.) 64 affective disorders 64 affective psychosis 64 depressive symptom 64 MMSE scores 63 syndromal 63 Depressive symptoms 63 schizophreniform disorder 62 GBA mutations 62 extrapyramidal symptoms 62 depressive symptoms 61 subclinical atherosclerosis 61 affective disorder 61 comorbid depression 61 BMI z 61 episodic migraine 61 neurocognitive deficits 61 autonomic dysfunction 61 comorbid anxiety 61 white matter hyperintensities 60 euthymic patients 60 prodrome 60 somatic symptoms 60 comorbid disorders 60 psychosocial functioning 60 Suicidal ideation 59 manic hypomanic 59 DSM IV diagnosis 59 neuroimaging studies 59 lipid abnormalities 59 euthymic 59 atypical neuroleptics 59 subsyndromal 59 APOE ε4 59 depressive symptomatology 59 somatoform disorders 59 dysthymic disorder 59 neurobehavioural 59 clinicopathological 59 behavioral disinhibition 59 subthreshold 59 unprovoked seizures 59 attention-deficit/hyperactivity disorder ADHD 59 suicide attempters 59 gene APOE 58 cortisol secretion 58 neurocognitive function 58 prevalences 58 univariate analyzes 58 hypersomnia 58 coronary calcification 58 symptom severity 58 hematopoietic cancers 58 hippocampal volumes 58 nondemented 58 juvenile idiopathic arthritis JIA 58 pharmacologic treatments 58 nonalcoholic steatohepatitis NASH 58 dysthymia 58 subsyndromal depression 58 cognitive affective 58 MetS 58 cranial irradiation 58 neuropathologic 58 diabetes mellitus DM 58 hypochondriasis 58 Cognitive impairment 58 diagnosing ADHD 58 neurodevelopmental impairment 58 primary aldosteronism 58 mania hypomania 58 HAM D# 58 MMSE score 58 generalized epilepsy 58 premorbid 58 Excessive daytime sleepiness 57 BPRS 57 psychotic symptoms 57 APOE genotype 57 prodromal phase 57 hippocampal volume 57 perimenopausal women 57 comorbid psychiatric 57 Subgroup analyzes 57 AUDs 57 dopamine receptor gene 57 prodromal symptoms 57 overt hypothyroidism 57 GH deficiency 57 virological response 57 internalizing disorders 57 alexithymia 57 psychiatric morbidity 57 neurologic symptoms 57 subclinical hypothyroidism 57 comorbid ADHD 57 familial clustering 57 penetrance 57 dysthymic 57 chronicity 57 prodromal 57 carotid IMT 57 habitual snoring 57 Brief Psychiatric 57 T2DM 57 psychosocial variables 57 hypoactive 57 non aspirin NSAIDs 57 SRBD 57 EoE 57 comorbid 57 MGUS 57 highly heritable 56 nondepressed 56 neuropsychiatric symptoms 56 colorectal adenoma 56 hyperactivity inattention 56 nonpsychotic 56 hypomania 56 haematologic 56 neurocognitive impairment 56 Comorbidity 56 schizophrenia schizoaffective disorder 56 thiopurine 56 affective psychoses 56 recurrent wheezing 56 PsA 56 carotid stenosis 56 psychotic disorders 56 cardio metabolic 56 HRQOL 56 somatization disorder 56 ADAS Cog 56 gross hematuria 56 psychiatric comorbidity 56 airway hyper responsiveness 56 hereditary predisposition 56 autoimmune thyroiditis 56 EDSS scores 56 oxcarbazepine 56 DSM IV Axis 56 TEAEs 56 logistic regression model 56 basal cell nevus syndrome 56 reflux symptoms 56 ALT flares 56 neurocognitive functioning 56 #q#.# deletion syndrome 56 SSRI citalopram 56 atopic 56 salivary cortisol 56 proliferative diabetic retinopathy 55 abdominal adiposity 55 posttreatment 55 parkinsonism 55 microsatellite instability 55 Genetic predisposition 55 emotional lability 55 schizophrenia 55 neurological abnormalities 55 severe hypoglycemia 55 URTI 55 QIDS SR 55 Autistic Disorder 55 chi squared 55 transaminase elevations 55 elevated ALT 55 AGILECT R 55 SGAs 55 somatization 55 HRQL 55 intractable epilepsy 55 RET PTC rearrangements 55 aetiology 55 bivariate analyzes 55 hypomanic symptoms 55 severe hypoglycaemia 55 MTHFD1L gene 55 psychiatric comorbidities 55 citalopram 55 externalizing disorders 55 covariate 55 prolonged QT interval 55 neuroleptics 55 predisposing factor 55 tumor histology 55 NIH CPSI 55 liver metastasis 55 sd = 55 APOE e4 55 neurodevelopmental outcome 55 compulsive hoarding syndrome 55 bulimia nervosa 55 suicidal ideation 55 5 HTT gene 55 generalized seizures 55 Observational studies 55 attention-deficit/hyperactivity disorder 55 â ‰ ¥ 55 carotid atherosclerosis 55 atopy 55 PSADT 55 albumin excretion 55 elevated CRP 55 STEP BD 55 Heritability 55 neuroleptic drugs 55 Interpersonal psychotherapy 55 schizotypal traits 55 nonobese 55 CP CPPS 55 subclinical hyperthyroidism 55 rCBF 55 neuropsychological deficits 55 macroalbuminuria 55 parkinsonian 55 narcolepsy cataplexy 55 CIN3 55 intracranial hypertension 55 #q# deletion syndrome 55 acetabular dysplasia 55 hypertension diabetes mellitus 55 YMRS 55 prepubertal 55 subscales 55 untreated celiac disease 55 symptomatology 55 adenotonsillectomy 55 T1DM 55 chlamydial infection 55 neuroleptic 55 PHQ 9 55 incidentalomas 55 solifenacin 55 Suicidal thoughts 55 subscale scores 55 Leydig cell 55 stratifying patients 55 nonfasting triglyceride levels 55 bivariate 55 Oppositional Defiant Disorder 55 Neuroticism 54 mood disorders 54 psychopathic traits 54 neuropsychological impairments 54 carbohydrate intolerance 54 clobazam 54 puerperal psychosis 54 HAMD 54 slow metabolizers 54 penile vaginal intercourse 54 amisulpride 54 antenatal depression 54 rhinoconjunctivitis 54 comorbid psychiatric disorders 54 hepatic lesions 54 lamotrigine 54 esotropia 54 subscores 54 premenopause 54 antihypertensive therapy 54 migraineurs 54 symptomology 54 status epilepticus 54 EXJADE 54 cognitive dysfunction 54 thyrotropin levels 54 Montgomery Åsberg Depression 54 sub syndromal 54 methotrexate monotherapy 54 psychiatric diagnoses 54 NNRTI resistance 54 underactive thyroids 54 bullous 54 hypomanic episodes 54 ADPKD 54 symptom checklist 54 nocturnal hypoglycemia 54 postoperative complication 54 Genetic variants 54 nonsignificant 54 schizophreniform 54 autistic traits 54 probands 54 comorbidity 54 dopamine transporter gene 54 pathophysiological mechanisms 54 substance induced psychosis 54 anticonvulsants 54 paraneoplastic 54 AGILECT ® 54 astrocytomas 54 pregabalin 54 relapsing remitting 54 fasting insulin 54 lipid lowering therapy 54 5 HTTLPR 54 risperidone Risperdal 54 polyp recurrence 54 osteosarcomas 54 tic disorders 54 impaired fasting glucose 54 neurosensory 54 APOE e4 gene 54 esophageal squamous cell carcinoma 54 poorer prognosis 54 longitudinal studies 54 unipolar depression 54 serum homocysteine 54 airway hyperresponsiveness 54 psychotic illness 54 amenorrhea 54 ADHD symptoms 54 Symptom Checklist 54 multivariable analysis 54 antidiabetic medication 54 Atypical antipsychotics 54 shorter telomere length 54 advanced adenomas 54 Anxiety disorders 54 neuropsychological impairment 54 mRS 54 generalized tonic clonic seizures 54 missense mutations 54 transaminase levels 54 cryptogenic 54 aortic atherosclerosis 54 prescribed antipsychotics 54 interindividual variability 54 histological subtype 54 Parkinsonian Syndromes 54 pharmacological therapies 54 NNT = 54 NIHSS score 54 parous women 54 leukocyte counts 54 timepoints 54 syncopal 54 nasal polyposis 54 GABRA2 54 confounder 54 definite stent thrombosis 54 PNH patients 54 obstructive apnea 54 inattention hyperactivity 54 poststroke 54 impaired cognition 54 hepatic encephalopathy HE 54 sociodemographic characteristics 54 rheumatic disorders 54 Index CDAI 54 postnatally 54 apneic episodes 54 hypoglycemic episodes 54 exploratory endpoints 54 Wernicke encephalopathy 54 lowest tertile 54 familial pancreatic cancer 54 ADHD 54 IPL# 54 IPAH 54 artery stenosis 53 tricyclics 53 neuropsychological assessment 53 dissociative disorders 53 POAG 53 NIHSS 53 colorectal neoplasia 53 CC genotype 53 Longitudinal studies 53 fluoxetine Prozac 53 ragweed allergic 53 MADRS score 53 Kaplan Meier curve 53 idiopathic PAH 53 corticosteroid therapy 53 prospective longitudinal 53 atypical antipsychotic medications 53 multivariate analyzes 53 SLC#A# [002] 53 antiepileptics 53 Stent thrombosis 53 autosomal dominant inheritance 53 hyperglycaemia 53 alanine aminotransferase ALT 53 INVEGA ® 53 ICD shocks 53 neurologic complications 53 gestational diabetes mellitus 53 PCNSL 53 etiologic factors 53 opioid dependent 53 scintigraphic 53 hereditary nonpolyposis colorectal cancer 53 anticholinergics 53 hepatic cirrhosis 53 aminotransferase levels 53 androgen deficiency 53 paricalcitol 53 nighttime awakenings 53 progressive dyspnea 53 cognitive deficits 53 recurrent VTE 53 susceptibility loci 53 Crohn Disease Activity 53 maladaptive behaviors 53 seminomas 53 myoclonus 53 IBS C 53 vasomotor symptoms 53 VADT 53 metabolic abnormalities 53 tegaserod 53 Impaired glucose tolerance 53 Wernicke Korsakoff syndrome 53 multivariable adjusted 53 Generalized Anxiety Disorder 53 anemia hemoglobin 53 nonfatal MI 53 hypokalemia hypomagnesemia 53 guanfacine 53 demyelinating 53 clomipramine 53 elevated bilirubin 53 β blockers 53 psychostimulants 53 posttransplant 53 abnormal cytology 53 univariate 53 atopic disorders 53 neutropaenia 53 postoperative delirium 53 HOMA IR 53 CI -#.# 53 hsCRP levels 53 serotonin reuptake inhibitors 53 esophageal adenocarcinoma 53 DAS# scores 53 subclinical 53 cognitive impairment 53 tricyclic antidepressants TCAs 53 T1c 53 biochemical imbalance 53 neuropsychological tests 53 torsade de pointes 53 HDL2 53 cortical activation 53 postinjury 53 autism Asperger 53 SCN1A 53 nonsevere 53 gastrointestinal dysfunction 53 intermittent exotropia 53 elevated creatinine 53 untreated psychosis 53 nonmelanoma skin cancers 53 PREZISTA r arm 53 neurologic abnormalities 53 antidepressants SSRIs 53 paroxysmal AF 53 pulmonary dysfunction 53 prolactin elevation 53 cognitive domains 53 symptomatic VTE 53 thyroid dysfunction 53 psychopathology 53 Primary IGFD 53 onsets 53 serum parathyroid hormone 53 suicide ideation 53 depression suicidal thoughts 53 hypoglycaemic episodes 53 NAFLD 53 serum vitamin D 53 genomic alterations 53 DSM IV criteria 53 elevated triglyceride levels 53 KIBRA 53 onset atrial fibrillation 53 insulin resistance syndrome 53 logistic regression analysis 53 Depression Inventory 53 nulliparous women 53 Mood disorders 53 systemic corticosteroid 53 overactive bladder symptoms 53 pharmacological therapy 53 abacavir Ziagen 53 prognostic variables 53 nondiabetic patients 53 utero exposure 53 Endothelial function 53 endophenotypes 53 hyperinsulinemic 53 intelligence quotient IQ 53 noncardiac 53 pyridostigmine 53 Cognitive behavioral 53 APOE gene 53 parasomnias 52 neurodevelopmental outcomes 52 Hashimoto thyroiditis 52 syndromic 52 meta analytic 52 Abilify aripiprazole 52 Univariate analysis 52 S. aureus isolates 52 conditional logistic regression 52 depressive episodes 52 asthma exacerbations 52 convergent validity 52 recurrent tonsillitis 52 colorectal adenomas 52 endometrial thickness 52 Binge eating 52 Sjögren syndrome 52 fructose intolerant 52 somatic complaints 52 attain statistical significance 52 recurrent miscarriage 52 adrenal function 52 akathisia 52 elevated LDH 52 nonautistic 52 VaD 52 BMI percentile 52 rheumatologic 52 EQ 5D 52 macrovascular disease 52 arterial thickening 52 IBDQ 52 thrombophilia 52 quetiapine 52 elevated homocysteine 52 serum cortisol 52 nonadherence 52 Selective serotonin reuptake inhibitors 52 imipramine 52 Nonspecific 52 dietary glycemic index 52 invasive ductal breast cancer 52 hydroxyvitamin D levels 52 Venous thromboembolism 52 % CI #.#-#.# [007] 52 CHADS 52 Afib 52 nonpregnant women 52 preoperative PSA 52 serum folate concentrations 52 cardioembolic stroke 52 pre pubertal 52 amnestic MCI 52 hyperacute 52 Rating Scale MADRS 52 serum IGF 52 RLS symptoms 52 asymptomatic PAD 52 autoimmune thyroid 52 stereotypy 52 muscle dysmorphia 52 chromosomal alterations 52 orchitis 52 sociodemographic factors 52 % CI #.#-#.# [003] 52 ADAS cog 52 HER2 expression 52 Comorbid 52 laboratory abnormalities 52 CVD mortality 52 developmental trajectories 52 HIV uninfected 52 hyperammonemia 52 ApoE gene 52 hepatic encephalopathy 52 #q# deletion 52 bipolar disorders 52 monozygotic twin 52 familial aggregation 52 agitation irritability 52 subclinical disease 52 bipolar mania trials 52 Chronic pancreatitis 52 etiologic 52 XMRV infection 52 myopia nearsightedness 52 psychiatric disorders 52 anticonvulsant medications 52 diarrhea predominant IBS 52 bronchopulmonary dysplasia 52 venlafaxine Effexor 52 nonadherent 52 baseline HbA1c 52 #F FDG PET 52 abnormal lipid 52 allele frequencies 52 neurocognitive 52 somatostatin analogs 52 HER2 positive cancers 52 adenoidectomy 52 typical antipsychotics 52 SCr 52 exhaled nitric oxide 52 STN stimulation 52 inhaled budesonide 52 rheumatoid factor 52 atherothrombotic disease 52 lichen planus 52 disorder ASD 52 clinicopathologic 52 sCJD 52 genetic loci 52 HBeAg negative 52 anti epileptics 52 glycated hemoglobin levels 52 pediatric bipolar disorder 52 subtrochanteric 52 use disorders AUDs 52 histologically proven 52 bacteriuria 52 microbleeds 52 multivariate logistic regression 52 thyroid nodules 52 prognostic indicators 52 ATACAND 52 EBV infection 52 PFAPA 52 concomitant AEDs 52 maturational 52 gallstone disease 52 ApoE4 gene 52 stimulant medications 52 perceptual reasoning 52 clinically meaningful improvements 52 TT genotype 52 follicular lymphoma FL 52 enuresis 52 osteopenic 52 tricyclic antidepressant 52 HNPCC 52 elevated depressive symptoms 52 recurrent wheeze 52 psychosocial stressors 52 serum GGT 52 PSA kinetics 52 leukotriene receptor antagonists 52 Y BOCS 52 systolic hypertension 52 migraine prophylaxis 52 CYP#C# gene 52 polyarticular 52 bronchopulmonary dysplasia BPD 52 menarche 52 parietal cortices 52 neurocognition 52 noncognitive 52 nocturnal enuresis 52 spirometric 52 PNES 52 Relapsing remitting MS 52 serum estradiol 52 uncontrolled epilepsy 52 Exclusion criteria 52 Neuropsychological 52 oral anticoagulation 52 nonhereditary 52 Epworth Sleepiness Scale 52 Atomoxetine 52 silent myocardial ischemia 52 microalbuminuria 52 chromosomal rearrangement 52 underwent coronary angiography 52 neuro cognitive 52 Cognitive dysfunction 52 lesional 52 quetiapine Seroquel 52 Hamilton Rating Scale 52 knee osteoarthritis OA 52 synaesthetes 52 Anticonvulsants 52 breastfed infants 52 pilocytic astrocytomas 52 DRD4 gene 52 extensive metabolizers 52 hypometabolism 52 #.#ng/ml 52 divalproex sodium 52 VUR 52 adjunctive ABILIFY 52 glucose abnormalities 52 motor neuropathy 52 glycosylated hemoglobin HbA1c 52 hippocampal function 52 chromosomal anomalies 52 allostatic load 52 microscopic hematuria 52 nonalcoholic steatohepatitis 52 atypical nevi 52 artery calcification 52 heritable variation 52 mammographic density 52 meta analytic review 52 chronic periodontitis 52 Personality traits 52 cognitively normal 52 somatoform disorder 52 conventional antipsychotics 52 SNHL 52 pramipexole 52 prehypertensive 52 diagnosable 52 logistic regression models 52 serum BDNF 52 externalizing behaviors 52 canakinumab 52 vestibular dysfunction 52 intima media thickness IMT 52 sporadic ALS 52 CYP#D# inhibitor 52 adenoma recurrence 52 repeat allele 52 PANSS scores 52 histologically confirmed 52 bipolar affective disorder 52 psychophysiological 52 Rating Scale BPRS 52 Child Behavior Checklist 52 anterior temporal 52 prefrontal regions 52 dietary interventions 52 CONCERTA ® 52 genotypic resistance 52 MMSE 52 serum retinol 52 PASI scores 52 gait disturbances 52 neuropsychiatric diseases 52 serum lipid levels 52 androgen depletion 52 EEG abnormalities 51 syncopal episodes 51 confidence interval #.#-#.# 51 underlying pathophysiology 51 diagnosable disorder 51 depressive disorders 51 unfavorable cytogenetics 51 System IPSS 51 idiopathic intracranial hypertension 51 tranylcypromine 51 recurrent venous thromboembolism 51 Brugada syndrome 51 genetic polymorphisms 51 Posttraumatic Stress Disorder PTSD 51 fronto temporal dementia 51 GSTM1 gene 51 urolithiasis 51 mood dysregulation 51 electroencephalographic 51 chronic urticaria 51 daytime sleepiness 51 hyperintensities 51 nonischemic 51 CTEPH 51 SGPT 51 lipid lowering medications 51 hyperinsulinemia 51 monoclonal gammopathy 51 subthreshold depression 51 retrospective cohort 51 symptom flare ups 51 dyslipidaemia 51 CETP gene 51 vitamin D inadequacy 51 antiepileptic drugs 51 μg dl 51 haloperidol Haldol 51 fructose intolerance 51 Topiramate 51 proliferative retinopathy 51 antidepressant medications 51 multivariate adjustment 51 chronic hepatitis cirrhosis 51 gestational diabetes mellitus GDM 51 citalopram Celexa 51 WOMAC pain 51 RLS sufferers 51 antiepileptic medications 51 callous unemotional traits 51 asthma rhinitis 51 neurologic outcomes 51 newer atypical antipsychotics 51 intact parathyroid hormone 51 untreated sleep apnea 51 obstructive CAD 51 refractory anaplastic astrocytoma 51 major depressive disorder 51 olanzapine LAI 51 Bacterial vaginosis 51 relapsed MM 51 hormone receptor negative 51 T2D 51 bladder carcinoma 51 dystonic 51 nortriptyline 51 GH deficient 51 prospectively enrolled 51 antioxidant supplementation 51 hematologic parameters 51 nonpsychiatric 51 Prostate specific antigen 51 folate deficiency 51 Parkinsonian 51 Severe Primary IGFD 51 diagnosing autism 51 genetic locus 51 transferrin saturation 51 #OHD levels 51 neurocognitive dysfunction 51 VLBW infants 51 postmenopausal estrogen 51 eszopiclone 51 plasma adiponectin 51 HRQoL 51 Visual acuity 51 HADS 51 TGFBR1 * 6A 51 LV dysfunction 51 lactose malabsorption 51 Nocturia 51 neuropsychological functioning 51 aspirin NSAIDs 51 epigastric pain 51 posttest 51 antiandrogens 51 prostate cancer PCa 51 nonallergic rhinitis 51 subscore 51 frontotemporal dementia 51 metabolic syndrome MetS 51 abnormal lipids 51 poor metabolizers 51 aetiological 51 CR nPR 51 Symptom severity 51 psychomotor retardation 51 syncope fainting 51 normal karyotype 51 atopic asthma 51 hormone receptor status 51 urate levels 51 serum creatinine levels 51 predictive validity 51 decompensated heart failure 51 2 diabetes T2D 51 GABRA2 gene 51 Geriatric Depression 51 dyspareunia 51 androgen excess 51 polypoid lesions 51 sleeve lobectomy 51 vascular cognitive impairment 51 Social Phobia 51 Valproate 51 spontaneous mutations 51 tonic clonic seizures 51 testicular tumors 51 steatohepatitis 51 virologically 51 CCyR 51 comorbid conditions 51 intima media thickness 51 psychodynamic psychotherapy 51 Alzheimer pathology 51 Antisocial personality 51 vesicoureteral reflux 51 intraventricular hemorrhage 51 genital tract infections 51 prenatally exposed 51 hemoglobin A1c levels 51 subtests 51 perfusion abnormalities 51 acute psychosis 51 Exacerbations 51 analgesic medications 51 hematological parameters 51 COMT genotype 51 onset diabetes mellitus 51 Korsakoff syndrome 51 ER CHOP 51 haemorrhagic stroke 51 acamprosate 51 gastro oesophageal reflux 51 mild cognitive impairment 51 multivariate regression 51 neuro behavioral 51 rufinamide 51 glaucomatous 51 de novo AML 51 completely resected 51 biopsy Gleason 51 Schizoaffective Disorder 51 susceptibility gene 51 fragility fracture 51 HNSCC 51 daytime alertness 51 NSTEMI 51 arterial calcification 51 unrefreshing sleep 51 periprocedural MI 51 childhood disintegrative disorder 51 bronchogenic carcinoma 51 functioning autistics 51 postoperative mortality 51 cognitive functioning 51 coronary artery aneurysms 51 ataxias 51 juvenile idiopathic arthritis 51 Wechsler Memory 51 pathogenetic mechanisms 51 mg BID dose 51 Mania Rating Scale 51 fractional anisotropy 51 fetal malformations 51 CLBP 51 hemorrhagic complications 51 febrile seizure 51 PANSS 51 hypercalciuria 51 FDG uptake 51 Moderate drinkers 51 impair cognition 51 synesthetes 51 sensory gating 51 ABCB1 51 cognitively intact 51 sociodemographic variables 51 PSA nadir 51 heterozygotes 51 activity MAOA 51 bronchial hyperresponsiveness 51 treatment emergent AEs 51 comorbid diagnoses 51 Osteopenia 51 tertiles 51 FDG PET scans 51 thyroid hormone levels 51 mIU L 51 persistent pulmonary hypertension 51 HAQ DI 51 leucopenia 51 thromboembolic 51 obstructive sleep 51 divalproex 51 febrile convulsions 51 monoamine oxidase inhibitors 51 nondiabetics 51 virologic responses 51 Global Impression CGI 51 androgen deprivation 51 hyperactivity impulsivity 51 impair cognitive 51 pseudotumor cerebri 51 thrombocytopenic patients 51 TPMT 51 neuropathological 51 neurologic disorder 51 neurologic deficits 51 biochemical recurrence 51 clinically meaningful reductions 51 elevated serum creatinine 51 psychotic illnesses 51 de novo mutations 51 Fasting glucose 51 UPDRS 51 oxygen desaturation 51 leptin deficient mice 51 pentoxifylline 51 abstinent alcoholics 51 hyperreflexia 51 logistic regression analyzes 51 Aortic stenosis 51 inflammatory biomarkers 51 precancerous polyp 51 asthma exacerbation 51 late onset hypogonadism 51 APOE4 51 autistic regression 51 clinically asymptomatic 51 acute rheumatic fever 51 BLLs 51 antiphospholipid antibodies 51 proband 51 G allele 51 antiepileptic drugs AEDs 51 intravenous bisphosphonates 51 esophagitis 51 physiologic responses 51 Colon polyps 51 recurrent UTI 51 febrile seizures 51 obstructive sleep apnea

Back to home page